Pharma PR & Communications Summit West 2024

We’ve all seen the incongruous growth of enterprise value in other sectors. Why was WeWork worth so much before the crash? Why is Tesla one of the world’s most valuable companies when so many other car makers offer electric vehicles? Do the same perceptions that increase institutional and retail investor willingness to pay for a company’s stock apply in life sciences? And, most importantly, does corporate or above brand communications influence those perceptions?

We’re glad you asked.

Delivered with the typical flair and provocation that’s become his calling card, this presentation from WSJ best-selling author, Paul Dyer, will debut original research looking at the relationship between investor willingness to pay and factors like reputation and trust, as well as perception of innovation, vision, and leadership.